Currently, Pratik S. Multani is Chief Medical Officer at Oric Pharmaceuticals, Inc. Dr. Multani is also on the board of Chimerix, Inc. and Erasca, Inc. and Principal at American Board of Internal Medicine.

He previously occupied the position of Senior Director-Medical Research & Development at Biogen, Inc. and Senior Director-Medical Research at IDEC Pharmaceuticals Corp. (a subsidiary of Biogen, Inc.), Vice President-Clinical Development at Kalypsys, Inc., Chief Medical Officer of Kanisa Pharmaceuticals, Inc., Chief Medical Officer of Fate Therapeutics, Inc., Chief Medical Officer of Ignyta, Inc., Vice President-Clinical Development at Salmedix, Inc., Member of The General Hospital Corp., Principal at Harvard University and Member of Harvard Medical School.

He received an undergraduate degree from Yale University, a graduate degree from Harvard T.H. Chan School of Public Health and a doctorate from Harvard Medical School.